The expression of PD-L1 on melanoma cells is not only important to the maintenance of an immunosuppressive microenvironment, but it could also be an independent prognostic factor [67] and even represent a biomarker for predicting the efficacy of anti-PD1 antibodies in melanoma [68]. The gene discussed is CD274; the disease is melanoma.